Search research articles
Contact Us
Filters
Showing results (71-80 of 97) with videos related to
Page
of 10
Sort By:
The Oncologist
|
September 6, 2022
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
Sha Zhu, Yuchao Ni, Zilin Wang, et al.
Analytical Chemistry
|
December 29, 2025
Nanoflower-Shaped Peptide Assemblies Driven by Serrated β-Sheets and Hydrophobic Interactions for High-Affinity MUC1 Recognition
Bokai Ma, Jinge Zhao, Shuang Li, et al.
Asian Journal of Surgery
|
November 14, 2022
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
Jinge Zhao, Guangxi Sun, Fengnian Zhao, et al.
European Journal of Medical Research
|
July 20, 2024
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma
Junjie Zhao, Xiuyi Pan, Zilin Wang, et al.
The Prostate
|
August 22, 2019
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Tao Wu, Jinge Zhao, Zhenhua Liu, et al.
Communications Medicine
|
September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes
Shu Ning, Jinge Zhao, Alan P Lombard, et al.
Clinical Epigenetics
|
August 8, 2022
Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma
Junjie Zhao, Jiayu Liang, Yang Yang, et al.
Angewandte Chemie (International Ed. in English)
|
January 7, 2026
Side-Chain Engineering Guides the Design of β-Sheet Inhibitor to Anchor Protein-Protein Interaction Interfaces
Limin Zhang, Minxuan Wang, Bo Wang, et al.
The Prostate
|
April 17, 2024
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
Fengnian Zhao, Jinge Zhao, Xinyuan Wei, et al.
The Prostate
|
August 26, 2021
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer
Zhipeng Wang, Sha Zhu, Jinge Zhao, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 97) with videos related to
Sort By:
Page
of 10
The Oncologist
|
September 6, 2022
Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
Sha Zhu, Yuchao Ni, Zilin Wang, et al.
Analytical Chemistry
|
December 29, 2025
Nanoflower-Shaped Peptide Assemblies Driven by Serrated β-Sheets and Hydrophobic Interactions for High-Affinity MUC1 Recognition
Bokai Ma, Jinge Zhao, Shuang Li, et al.
Asian Journal of Surgery
|
November 14, 2022
The therapeutic efficacy of radical prostatectomy and external beam radiation therapy in patients with different pathological patterns of prostate cancer
Jinge Zhao, Guangxi Sun, Fengnian Zhao, et al.
European Journal of Medical Research
|
July 20, 2024
Epigenetic modification of PHLDA2 is associated with tumor microenvironment and unfavorable outcome of immune checkpoint inhibitor-based therapies in clear cell renal cell carcinoma
Junjie Zhao, Xiuyi Pan, Zilin Wang, et al.
The Prostate
|
August 22, 2019
Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?
Tao Wu, Jinge Zhao, Zhenhua Liu, et al.
Communications Medicine
|
September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes
Shu Ning, Jinge Zhao, Alan P Lombard, et al.
Clinical Epigenetics
|
August 8, 2022
Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma
Junjie Zhao, Jiayu Liang, Yang Yang, et al.
Angewandte Chemie (International Ed. in English)
|
January 7, 2026
Side-Chain Engineering Guides the Design of β-Sheet Inhibitor to Anchor Protein-Protein Interaction Interfaces
Limin Zhang, Minxuan Wang, Bo Wang, et al.
The Prostate
|
April 17, 2024
Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67
Fengnian Zhao, Jinge Zhao, Xinyuan Wei, et al.
The Prostate
|
August 26, 2021
The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer
Zhipeng Wang, Sha Zhu, Jinge Zhao, et al.
Page
of 10